Little Green’s (ASX:LGP) Denmark facility dispatches first shipment

Highlights

  • The shipment by LGP's Denmark facility contains 50kg of cannabis flower medicine.
  • The medicines are to be sold across Australian pharmacies in 15g packs each.
  • The demand and sale of flower medicines in Australia continue to rise as doctors prescribe them to patients for quick relief.

The ASX-listed medical cannabis company Little Green Pharma Ltd (ASX:LGP) has announced that the Company has successfully shipped its first cannabis flower medicines to Australia from its recently acquired Danish Facility.

LGP has shared that the shipment contains 50kgs of its flower medicine, named after the eponymous Australian wildflower. LGP's Billy Buttons THC 16 has a THC content of 16% and is available in the Australian market in 15g packs.

LGP has also shared that its Billy Buttons THC 16 medicine is now made available for sale in Australia through all pharmacies. Moreover, in the announcement, LGP has also stated that it expects two more shipments of LGP cannabis flower medicines of 65kgs from the facility arriving within the end of October 2021.

Moreover, Australian pharmacies have witnessed a rise in dried flower medicine sales. The pharmacies have observed an increase in demand as doctors became more comfortable with this method of administration, with cannabis flower frequently prescribed due to its rapid onset of therapeutic benefit properties.

The announcement has also revealed that Little Green Pharma has appointed Morten Snede as the Chief Financial Officer and Tony Roberts as the Company's General Manager (EU).

About Little Green Pharma:

Little Green Pharma is an ASX-listed medical cannabis company that deals with the cultivation and production of cannabis through manufacturing and distributing. The Company also owns an indoor cultivation facility in Western Australia and an exclusive partnership TGAGMP-licensed pharmaceutical manufacturer that helps LGP produce its medical cannabis products.

The LGP stock closed 3.378% higher at AU$0.765 per share on the ASX today.

Bottomline:

LGP believes that the dispatch of the first shipment by the Denmark team has marked a significant achievement in the history of the Company. Flower medicines have grown tremendously popular in Australia as doctors prefer them to give quick relief to their patients.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK